The results of the CCK-8 assay indicated that while SORBS1 knockdown reversed the hindering consequence of low-dose PPH on pancreatic cancer viability in vitro, no significant influence was noted with high-dose PPH treatment. The gene discussed is SORBS1; the disease is familial pancreatic carcinoma.